Portal de Periódicos da CAPES

Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin

2019; Wiley; Volume: 24; Issue: 7 Linguagem: Inglês

10.1111/resp.13486

1440-1843

Angelico Mendy, Radha Gopal, John F. Alcorn, Erick Forno,

Diabetes Treatment and Management

Chronic lower respiratory diseases (CLRD) increase the risk of type 2 diabetes, which in turn may worsen lung function. Metformin, a common antidiabetic with anti-inflammatory and antioxidant properties, may improve respiratory outcomes. Therefore, we examined the association of metformin use with the risk of mortality from CLRD.